ENZON PHARMS INC (ENZN) SEC filings
ENZN SEC filings moved a median of 0.00% by the close. ENZN SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ENZN overview →
52 measured ENZN SEC filing events.
Where these ENZN SEC filings landedvs 49 measured ENZN SEC filing reactions
| Middle 50% of ENZN SEC filing reactions | -2.47% to +7.53% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 49 |
Point-in-time · zero look-ahead
Half of the 49 ENZN SEC filing events with a measured close landed between -2.47% and +7.53%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K ENZON PHARMACEUTICALS, For: Mar 25 | SEC filing · Form 8-K | — | — | |
| Form 8-A12G/A ENZON PHARMACEUTICALS, | SEC filing · Form 8-A12G | +0.00% | -2.00% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Mar 20 | SEC filing · Form 8-K | +0.00% | -2.00% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Mar 19 | SEC filing · Form 8-K | +0.00% | +10.70% | |
| Form 8-A12G/A ENZON PHARMACEUTICALS, | SEC filing · Form 8-A12G | +0.00% | +0.00% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Mar 18 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Mar 16 | SEC filing · Form 8-K | +9.64% | +18.18% | |
| Form 8-A12G/A ENZON PHARMACEUTICALS, | SEC filing · Form 8-A12G | +0.00% | +7.43% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Mar 10 | SEC filing · Form 8-K | +0.00% | +7.43% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Mar 09 | SEC filing · Form 8-K | +0.00% | +42.05% | |
| Form 10-K ENZON PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| Form 8-A12G/A ENZON PHARMACEUTICALS, | SEC filing · Form 8-A12G | +0.00% | -2.00% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Feb 27 | SEC filing · Form 8-K | +0.00% | -2.00% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Feb 11 | SEC filing · Form 8-K | -3.27% | +6.84% | |
| Form EFFECT ENZON PHARMACEUTICALS, | SEC filing · Form EFFECT | +0.00% | +0.13% | |
| Form 8-A12G/A ENZON PHARMACEUTICALS, | SEC filing · Form 8-A12G | +0.00% | +10.81% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Jan 30 | SEC filing · Form 8-K | +0.00% | +10.81% | |
| Form S-4/A ENZON PHARMACEUTICALS, | SEC filing · Form S-4 | +0.00% | +10.81% | |
| Form S-4 ENZON PHARMACEUTICALS, | SEC filing · Form S-4 | +0.00% | -2.47% | |
| Form 8-A12G/A ENZON PHARMACEUTICALS, | SEC filing · Form 8-A12G | +0.00% | -1.17% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Dec 23 | SEC filing · Form 8-K | +0.00% | -1.17% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | +11.11% | — | |
| Form 8-K ENZON PHARMACEUTICALS, For: Oct 24 | SEC filing · Form 8-K | +0.00% | -16.78% | |
| Form 8-A12G/A ENZON PHARMACEUTICALS, | SEC filing · Form 8-A12G | +0.37% | -1.85% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 8-K | +0.37% | -1.85% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +3.95% | |
| Form 8-A12G/A ENZON PHARMACEUTICALS, | SEC filing · Form 8-A12G | +0.00% | +3.95% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Jun 20 | SEC filing · Form 8-K | -1.17% | -25.84% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +7.53% | |
| Form 10-K/A ENZON PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.69% | |
| Form 8-A12G/A ENZON PHARMACEUTICALS, | SEC filing · Form 8-A12G | +0.00% | +34.06% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 8-K | +0.00% | +34.06% | |
| Form 10-K ENZON PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -10.00% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Jan 07 | SEC filing · Form 8-K | -12.90% | -16.16% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Dec 18 | SEC filing · Form 8-K | +0.00% | -5.88% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Sep 26 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -5.65% | |
| Form ARS ENZON PHARMACEUTICALS, For: Dec 31 | SEC filing · Form ARS | +0.00% | -5.65% | |
| Form DEF 14A ENZON PHARMACEUTICALS, For: Sep 26 | SEC filing · Form DEF | +0.00% | -5.65% | |
| Form DEFA14A ENZON PHARMACEUTICALS, | SEC filing · Form DEFA14A | +0.00% | -5.65% | |
| Form PRE 14A ENZON PHARMACEUTICALS, For: Sep 26 | SEC filing · Form PRE | +14.14% | +14.14% | |
| Form 8-K/A ENZON PHARMACEUTICALS, For: Jul 02 | SEC filing · Form 8-K | +0.00% | +6.25% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Jul 02 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Jun 10 | SEC filing · Form 8-K | +0.00% | +15.20% | |
| Form 8-A12G/A ENZON PHARMACEUTICALS, | SEC filing · Form 8-A12G | +0.00% | -11.50% | |
| Form 8-K ENZON PHARMACEUTICALS, For: May 16 | SEC filing · Form 8-K | +0.00% | -11.50% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | -6.06% | -2.94% | |
| Form 10-K/A ENZON PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | — | — | |
| Form 10-K ENZON PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +33.33% | +33.33% | |
| Form 8-K ENZON PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 8-K | -10.81% | +9.51% | |
| Form 10-Q ENZON PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.00% |
Keep exploring
More ENZN: earnings → · analyst actions → · ENZN overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Titan Pharmaceuticals, Inc. (TTNP) | 94 | +0.47% | 61% |
| COGNETIVITY NEUROSCIENCES (CGNSF) | 93 | 0.00% | 37% |
| HEMACARE CORP (HEMA) | 91 | 0.00% | 23% |
| Telesis Bio, Inc. (TBIO) | 91 | 0.00% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.